Chemokine (C-C Motif) ligand 5 is involved in tumor-associated dendritic cell-mediated colon cancer progression through non-coding RNA MALAT-1

Journal of Cellular Physiology

Volumn 230, Issue 8, 2015, Pages 1883-1894

  Kan, Jung Yu ^a,b   Wu, Deng Chyang ^b,c   Yu, Fang Jung ^b,c   Wu, Cheng Ying ^a   Ho, Ya Wen ^a   Chiu, Yen Jung ^a,b   Jian, Shu Fang ^c   Hung, Jen Yu ^c   Wang, Jaw Yuan ^a,b,d   Kuo, Po Lin ^a,d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; NEUTRALIZING ANTIBODY; RANTES; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UNTRANSLATED RNA; CCL5 PROTEIN, HUMAN; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN;

ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CELL INVASION; CELL MIGRATION; CELL STIMULATION; CELL VIABILITY; CELLULAR SECRETION; COLON CANCER; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR MIMICRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; UPREGULATION; CELL MOTION; COLON TUMOR; DISEASE COURSE; DNA MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

GASTROPODA;

CELL MOVEMENT; CHEMOKINE CCL5; COLONIC NEOPLASMS; DENDRITIC CELLS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR MICROENVIRONMENT;

EID: 84928379050     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24918     Document Type: Article

References (45)

1. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, García JM, Muñoz A, Esteller M, González-Sancho JM. 2006. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25:4116-4121.
2. Borczuk AC, Papanikolaou N, Toonkel RL, Sole M, Gorenstein LA, Ginsburg ME, Sonett JR, Friedman RA, Powell CA. 2008. Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. Oncogene 27:557-564.
3. Calore F, Lovat F, Garofalo M. 2013. Non-coding RNAs and cancer. Int J Mol Sci 14:17085-17110.
4. Danese S, Mantovani A. 2010. Inflammatory bowel disease and intestinal cancer: A paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene 29:3313-3323.
5. Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY. 2012. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res 72:1092-1102.
6. Gajewski TF, Schreiber H, Fu YX. 2013. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014-1022.
7. Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, van Rooijen N, Anderson GM, Nemeth JA, Strohl WR, Jordan RE, Brezski RJ. 2012. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. J Immunol 189:5457-5466.
8. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, Zörnig M, MacLeod AR, Spector DL, Diederichs S. 2013. The noncoding RNA MALAT-1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73:1180-1189.
9. He H, Chen W, Wang X, Wang C, Liu F, Shen Z, Xu J, Gu J, Sun Y. 2012. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci 103:1296-1303.
10. Hsu YL, Huang MS, Cheng DE, Hung JY, Yang CJ, Chou SH, Kuo PL. 2011. Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression. J Immunol 187:1733-1744.
11. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22:8031-8041.
12. Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG. 2010. C-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Che 285:8218-8226.
13. Kato T, Fujita Y, Nakane K, Mizutani K, Terazawa R, Ehara H, Kanimoto Y, Kojima T, Nozawa Y, Deguchi T, Ito M. 2013. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9and by activating ERK and Rac signaling. Cytokine 64:251-257.
14. Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. 2013. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associatedtumorigenesis. Cancer Cell 24: 631-644.
15. Kroepil F, Fluegen G, Vallböhmer D, Baldus SE, Dizdar L, Raffel AM, Hafner D, Stoecklein NH, Knoefel WT. 2013. Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters. BMC Cancer 13:145.
16. Kuo PL, Huang MS, Hung JY, Chou SH, Chiang SY, Huang YF, Yang CJ, Tsai MJ, Chang WA, Hsu YL. 2014. Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression. Int J Cancer 135:96-108.
17. Lin R, Maeda S, Liu C, Karin M, Edgington TS. 2007. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26:851-858.
18. Lin S, Wan S, Sun L, Hu J, Fang D, Zhao R, Yuan S, Zhang L. 2012. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia. Cancer Sci 103:904-912.
19. Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E. 2008. Chemotherapeutic drugs and human tumor cells cytokine network. Int J Cancer 123:2031-2040.
20. Lin SJ, Chang KP, Hsu CW, Chi LM, Chien KY, Liang Y, Tsai MH, Lin YT, Yu JS. 2013. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma. J Proteomics 94C:186-201.
21. Liu Y, Han ZP, Zhang SS, Jing YY, Bu XX, Wang CY, Sun K, Jiang GC, Zhao X, Li R, Gao L, Zhao QD, Wu MC, Wei LX. 2011. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem 286:25007-25015.
22. Mackay CR. 2001. Chemokines: Immunology's high impact factors. Nat Immunol 2:95-101.
23. Matsui A, Yokoo H, Negishi Y, Endo-Takahashi Y, Chun NA, Kadouchi I, Suzuki R, Maruyama K, Aramaki Y, Semba K, Kobayashi E, Takahashi M, Murakami T. 2012. CXCL17 expression by tumor cells recruits CD11b + Gr1 high F4/80- cells and promotes tumor progression. PLoS ONE 7:e44080.
24. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC. 2011. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis 32:477-487.
25. Moran CJ, Arenberg DA, Huang CC, Giordano TJ, Thomas DG, Misek DE, Chen G, Iannettoni MD, Orringer MB, Hanash S, Beer DG. 2002. RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res 8:3803-3812.
26. Moreno-Bueno G, Portillo F, Cano A. 2008. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27:6958-6969.
27. Peltekova VD, Lemire M, Qazi AM, Zaidi SH, Trinh QM, Bielecki R, Rogers M, Hodgson L, Wang M, D'Souza DJ, Zandi S, Chong T, Kwan JY, Kozak K, De Borja R, Timms L, Rangrej J, Volar M, Chan-Seng-Yue M, Beck T, Ash C, Lee S, Wang J, Boutros PC, Stein LD, Dick JE, Gryfe R, McPherson JD, Zanke BW, Pollett A, Gallinger S, Hudson TJ. 2014. Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants. Int J Cancer 134:2330-2341.
28. Peña C, García JM, Larriba MJ, Barderas R, Gómez I, Herrera M, García V, Silva J, Domínguez G, Rodríguez R, Cuevas J, de Herreros AG, Casal JI, Muñoz A, Bonilla F. 2009. SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene 28:4375-4385.
29. Perez DS, Hoage TR, Pritchett JR, Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS, Smith DI. 2008. Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet 17:642-655.
30. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, Zanovello P. 2013. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 14:589.
31. Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J, Hou J, Gao X, Xu C, Huang J, Zhao Y, Sun Y. 2013. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol 190:2278-2287.
32. Schmidt LH, Spieker T, Koschmieder S, Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D, Marra A, Hillejan L, Wiebe K, Berdel WE, Wiewrodt R, Muller-Tidow C. 2011. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 6:1984-1992.
33. Shih JY, Yang PC. 2011. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 32:1299-1304.
34. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
35. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M, Ben-Baruch A. 2011. Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11:130.
36. Stemmer V, de Craene B, Berx G, Behrens J. 2008. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 27:5075-5080.
37. Sugasawa H, Ichikura T, Tsujimoto H, Kinoshita M, Morita D, Ono S, Chochi K, Tsuda H, Seki S, Mochizuki H. 2008. Prognostic significance of expression ofCCL5/RANTES receptors in patients with gastric cancer. J Surg Oncol 97:445-450.
38. Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, Scherag A, Hütte J, Dominas N, Lehnerdt GF, Hoffmann TK, Lang S, Brandau S. 2011. Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 129:2183-2193.
39. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, Blencowe BJ, Prasanth SG, Prasanth KV. 2010. The nuclear-retained noncoding RNA MALAT-1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39:925-938.
40. Tsai MJ, Chang WA, Huang MS, Kuo PL. 2014. Tumor microenvironment: A new treatment target for cancer. ISRN Biochem 2014:351959.
41. Ungerbäck J, Belenki D, Jawad ul-Hassan, Fredrikson A, Fransén M, Elander K, Verma N, Söderkvist D. 2012. Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis 33:2126-2134.
42. Yi EH, Lee CS, Lee JK, Lee YJ, Shin MK, Cho CH, Kang KW, Lee JW, Han W, Noh DY, Kim YN, Cho IH, Ye SK. 2013. STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 11:31-42.
43. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. 2012. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 8:2289-2294.
44. Yokota J. 2000. Tumor progression and metastasis. Carcinogenesis 21:497-503.
45. Zhang Y, Lv D, Kim HJ, Kurt RA, Bu W, Li Y, Ma X. 2013. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells. Cell Res 23:394-408.